Vagus Nerve Stimulation Market to reach USD 1,074.62 Million by 2032, and grow at a CAGR of 10.48%
The market for neurostimulation devices is increasing, which also led to finding a better class that has minimal side effects and thus is optimal therapy. Neurological conditions account for 4.5%-11% of all illnesses as estimated by the WHO, in low or high-income countries alike This figure is greater than that of respiratory diseases, gastrointestinal problems, or certain cancers, and further, his burden will probably experience a rise in the future years.